{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:03:07Z","timestamp":1768467787312,"version":"3.49.0"},"reference-count":68,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Hepatic fibrosis is an effusive wound healing process, characterized by an excessive deposition of extracellular matrix (ECM), as the consequence of chronic liver injury of any etiology. Current therapeutic repertoire for hepatic fibrosis is limited to withdrawal of the noxious agent, which is not always feasible. Hence, in this article, the antifibrotic effects and possible mechanisms of r-sHSA, a recombinant protein with hepatoprotection potential, were investigated. Using NIH\/3T3 (mouse embro-fibroblast cell line), skin fibroblasts (human skin fibroblasts, SFBs) and HSC-T6 (rat hepatic stellate cell line), the in vitro effect of r-sHSA was evaluated by measuring the expression levels of alpha-1 Type I collagen (Col1A1) and \u03b1-smooth muscle actin (\u03b1-SMA). It turned out those fibrosis indicators were typically inhibited by r-sHSA, suggesting its capacity in HSCs inactivation. The antifibrotic activity of r-sHSA was further investigated in vivo on  CCl4-induced hepatic fibrosis, in view of significant improvement of the biochemical and histological indicators. More specifically, CCl4-intoxication induced a significant increase in serological biomarkers, e.g., transaminase (AST, ALT), and alkaline phosphatase (ALP), as well as disturbed hepatic antioxidative status; most of the parameters were spontaneously ameliorated to a large extent by withdrawal of CCl4, although the fibrotic lesion was observed histologically. In contrast, r-sHSA treatment markedly eliminated fibrous deposits and restored architecture of the liver in a dose dependent manner, concomitantly with the phenomena of inflammation relief and HSCs deactivation. To sum up, these findings suggest a therapeutic potential for r-sHSA in hepatic fibrosis, though further studies are required.<\/jats:p>","DOI":"10.3390\/md13085201","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T10:31:11Z","timestamp":1439893871000},"page":"5201-5218","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo"],"prefix":"10.3390","volume":"13","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[{"name":"School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boping","family":"Ye","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"key":"ref_1","unstructured":"Zakim, D., Boyer, T.D., Manns, M.P., and Sanyal, A.J. (2011). Zakim and Boyer\u2019s Hepatology: A Textbook of Liver Disease, Elsevier Health Sciences. [6th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis","volume":"21","author":"Bataller","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2741\/reeves","article-title":"Activation of hepatic stellate cells\u2014A key issue in liver fibrosis","volume":"7","author":"Reeves","year":"2002","journal-title":"Front. Biosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0142-9612(03)00508-8","article-title":"Animal models of liver regeneration","volume":"25","author":"Palmes","year":"2004","journal-title":"Biomaterials"},{"key":"ref_6","first-page":"1","article-title":"Deaths: Leading causes for 2004","volume":"56","author":"Heron","year":"2007","journal-title":"Natl. Vital Stat. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.46.4.443","article-title":"Is liver fibrosis reversible?","volume":"46","author":"Benyon","year":"2000","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J. Clin. Invest."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.biocel.2009.03.001","article-title":"Hepatic stellate cell: A star cell in the liver","volume":"41","author":"Atzori","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0676.2001.210101.x","article-title":"Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells","volume":"21","author":"Saccomanno","year":"2001","journal-title":"Liver"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-5926-6-7","article-title":"Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options","volume":"6","author":"Gressner","year":"2007","journal-title":"Comp. Hepatol."},{"key":"ref_13","first-page":"111","article-title":"Cloning and sequence analysis of cDNA fragment of shark hepatic stimulator substance\u2019s similarity","volume":"1","author":"Ye","year":"2003","journal-title":"Chin. J. Nat. Med."},{"key":"ref_14","first-page":"37","article-title":"Expressing and bioactivity analysis of shark hepatic stimulate substance analogue in Escherichia coli","volume":"28","author":"Wang","year":"2004","journal-title":"Mar. Sci."},{"key":"ref_15","first-page":"368","article-title":"Effect of recombinant hepatical stimulator substance analogue on CCl4-induced acute liver injury in mice","volume":"36","author":"Wang","year":"2005","journal-title":"J. Chin. Pharm. Univ."},{"key":"ref_16","first-page":"375","article-title":"Protective effect of recombinant hepatical stimulator analogue on Concanavalin A-induced acute liver injury in mice","volume":"42","author":"Zhang","year":"2011","journal-title":"J. Chin. Pharm. Univ."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/01480547809034433","article-title":"Serum enzymes as indicators of chemically induced liver damage","volume":"1","author":"Drotman","year":"1978","journal-title":"Drug Chem. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","article-title":"The current state of serum biomarkers of hepatotoxicity","volume":"245","author":"Ozer","year":"2008","journal-title":"Toxicology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.pa.14.040174.001415","article-title":"Biochemical mechanisms of drug toxicity","volume":"14","author":"Gillette","year":"1974","journal-title":"Annu. Rev. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/hep.1840060108","article-title":"CCl4-induced toxicity in isolated hepatocytes: The importance of direct solvent injury","volume":"6","author":"Berger","year":"1986","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0163-7258(89)90050-8","article-title":"Mechanisms of carbon tetrachloride toxicity","volume":"43","author":"Recknagel","year":"1989","journal-title":"Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0748-5514(85)90026-1","article-title":"Pathological mechanisms in carbon tetrachloride hepatotoxicity","volume":"1","author":"Brattin","year":"1985","journal-title":"J. Free Radic. Biol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0300-483X(03)00157-4","article-title":"Carbon tetrachloride-induced lipid peroxidation: Eicosanoid formation and their regulation by antioxidant nutrients","volume":"189","author":"Basu","year":"2003","journal-title":"Toxicology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.3748\/wjg.v16.i48.6035","article-title":"Oxidative stress and antioxidants in hepatic pathogenesis","volume":"16","author":"Ha","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/ars.2014.5952","article-title":"Molecular strategies for targeting antioxidants to mitochondria: Therapeutic implications","volume":"22","author":"Apostolova","year":"2015","journal-title":"Antioxid. Redox Signaling"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitsis","volume":"127","author":"Dufour","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_29","first-page":"1333","article-title":"Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat","volume":"137","author":"Lebeau","year":"1990","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.taap.2009.09.001","article-title":"Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin","volume":"241","author":"Jakovac","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/15216540051081010","article-title":"Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems","volume":"50","author":"Davies","year":"2000","journal-title":"IUBMB Life"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1089\/ars.2009.2692","article-title":"Adaptation to oxidative stress, chemoresistance, and cell survival","volume":"11","author":"Landriscina","year":"2009","journal-title":"Antioxid. Redox Signaling"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","article-title":"Evaluation of liver fibrosis: A concise review","volume":"99","author":"Afdhal","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","article-title":"Mechanisms of liver fibrosis","volume":"364","author":"Tsukada","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"The cellular basis of hepatic fibrosis\u2014Mechanisms and treatment strategies","volume":"328","author":"Flier","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.pharmtox.45.120403.095906","article-title":"Hepatic fibrosis: Molecular mechanisms and drug targets","volume":"45","author":"Lotersztajn","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: The principal collagen-producing cells of normal rat liver","volume":"82","author":"Friedman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tox.2008.08.017","article-title":"Hepatic fibrogenesis: From within and outwith","volume":"254","author":"Henderson","year":"2008","journal-title":"Toxicology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-1007105","article-title":"Cytokines and Fibrogenesis","volume":"19","author":"Friedman","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1530-0277.1999.tb04202.x","article-title":"Cytokine regulation of hepatic stellate cells in liver fibrosis","volume":"23","author":"Tsukamoto","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","article-title":"Chemokines in liver inflammation and fibrosis","volume":"30","author":"Wasmuth","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0168-8278(99)80007-5","article-title":"Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-\u03b1 and TGF-\u03b21","volume":"30","author":"Knittel","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/gressner","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"Gressner","year":"2002","journal-title":"Front. Biosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-\u03b2 as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2005-858989","article-title":"TGF-beta\/smad signaling in the injured liver","volume":"44","author":"Breitkopf","year":"2006","journal-title":"Z. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-419X(90)90013-Q","article-title":"The cell biology of transforming growth factor \u03b2","volume":"1032","author":"Barnard","year":"1990","journal-title":"Biochim. Biophy. Acta Rev. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0021-9258(18)94267-5","article-title":"Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta","volume":"264","author":"Overall","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2010.03.016","article-title":"Antifibrotic activity of anthocyanidin delphinidin in carbon tetrachloride-induced hepatotoxicity in mice","volume":"272","author":"Jakovac","year":"2010","journal-title":"Toxicology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis: From the bench to clinical targets","volume":"36","author":"Pinzani","year":"2004","journal-title":"Dig. Liver Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510310123","article-title":"Increased toxin-induced liver injury and fibrosis in Interleukin-6\u2013Deficient mice","volume":"31","author":"Kovalovich","year":"2000","journal-title":"Hepatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: The nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2002.35953","article-title":"Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis","volume":"123","author":"Canbay","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gut.2004.053850","article-title":"Apoptosis: A mechanism of acute and chronic liver injury","volume":"54","author":"Guicciardi","year":"2005","journal-title":"Gut"},{"key":"ref_58","first-page":"1371","article-title":"High cell-density fermentation of shark hepatical stimulator analogue in Escherichia coli","volume":"25","author":"Ye","year":"2009","journal-title":"Chin. J. Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2470597","article-title":"Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts","volume":"247","author":"Varga","year":"1987","journal-title":"Biochem. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/excr.2000.4930","article-title":"Modulation of endogenous smad expression in normal skin fibroblasts by transforming growth factor-\u03b2","volume":"258","author":"Mori","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"39058","DOI":"10.1074\/jbc.M506921200","article-title":"Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_62","first-page":"S967","article-title":"Adiponectin has potent anti-fibrotic effects mediated via amp kinase: Novel target for fibrosis therap","volume":"64","author":"Fang","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.fsi.2013.09.010","article-title":"Molecular cloning of the alpha subunit of complement component C8 (CpC8\u03b1) of whitespotted bamboo shark (Chiloscyllium plagiosum)","volume":"35","author":"Wang","year":"2013","journal-title":"Fish Shellfish Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-8278(02)00102-2","article-title":"Leptin is essential for the hepatic fibrogenic response to chronic liver injury","volume":"37","author":"Leclercq","year":"2002","journal-title":"J. Hepatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: A need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jep.2009.09.009","article-title":"The hepatoprotective and antifibrotic effects of saururus chinensis against carbon tetrachloride induced hepatic fibrosis in rats","volume":"126","author":"Wang","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11373-006-9079-5","article-title":"Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats","volume":"13","author":"Chong","year":"2006","journal-title":"J. Biomed. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/jcp.48.12.1093","article-title":"Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases","volume":"48","author":"Takiya","year":"1995","journal-title":"J. Clin. Pathol."}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/13\/8\/5201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:46:56Z","timestamp":1760215616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/13\/8\/5201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8]]}},"alternative-id":["md13085201"],"URL":"https:\/\/doi.org\/10.3390\/md13085201","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]}}}